Impact of a Low-Dose Combination of Isradipine SRO and Spirapril on Left Ventricular Mass and Left Ventricular Performance in Patients with Hypertension and Left Ventricular Hypertrophy

被引:0
作者
David Pittrow
Gottfried Weidinger
Thomas Stoerk
Hermann Eichstaedt
机构
[1] Technical University of Dresden,Department of Clinical Pharmacology, Medical Faculty
[2] Novartis Pharma GmbH,Department of Clinical Research
[3] Karl-Olga Hospital,Department of Cardiology
[4] Humboldt-University of Berlin,Department of Cardiology, Virchow
[5] Technical University of Dresden,Clinic of the Charité
来源
Clinical Drug Investigation | 2002年 / 22卷
关键词
Left Ventricular Hypertrophy; Leave Ventricular Mass Index; Moderate Hypertension; Isradipine; Peak Filling Rate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:667 / 675
页数:8
相关论文
共 50 条
  • [1] Effects of a low-dose combination of isradipine and an ACE-inhibitor on left ventricular mass and left ventricular performance
    Eichstädt, H
    Pittrow, D
    Störk, T
    PERFUSION, 2002, 15 (08): : 317 - +
  • [2] Further evidence for low-dose combinations in patients with left ventricular hypertrophy
    Dahlöf, B
    JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (Suppl 1) : S9 - S14
  • [3] Left ventricular contractile performance, ventriculoarterial coupling, and left ventricular efficiency in hypertensive patients with left ventricular hypertrophy
    Nitenberg, A
    Antony, I
    Loiseau, A
    AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (10) : 1188 - 1198
  • [4] Hypertension and left ventricular hypertrophy
    Dordevic, Dragan B.
    Koracevic, Goran P.
    Dordevic, Aleksandar D.
    Lovic, Dragan B.
    JOURNAL OF HYPERTENSION, 2024, 42 (09) : 1505 - 1515
  • [5] Further evidence for low-dose combinations in patients with left ventricular hypertrophy
    B Dahlöf
    Journal of Human Hypertension, 2005, 19 : S9 - S14
  • [6] Left ventricular hypertrophy and hypertension
    Yildiz, Mehmet
    Oktay, Ahmet Afsin
    Stewart, Merrill H.
    Milani, Richard V.
    Ventura, Hector O.
    Lavie, Carl J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2020, 63 (01) : 10 - 21
  • [7] Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension
    Ratto, Elena
    Leoncini, Giovanna
    Viazzi, Francesca
    Bezante, Gian Paolo
    Falqui, Valeria
    Parodi, Angelica
    Conti, Novella
    Tomolillo, Cinzia
    Deferrari, Giacomo
    Pontremoli, Roberto
    JOURNAL OF HYPERTENSION, 2008, 26 (02) : 345 - 350
  • [8] The Effects of Simvastatin on Left Ventricular Hypertrophy and Left Ventricular Function in Patients with Essential Hypertension
    Pan, Xiu-Di
    Zeng, Zhao-Hua
    Liang, Li-Ying
    Luo, Jian-Dong
    Xiao, Ai-Yi
    Lai, Qing
    Wen, Yan-Hang
    Lu, Dong-Feng
    Wang, Wei
    He, Zhao-Chu
    He, Wen-Kai
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33 (08) : 558 - 564
  • [9] Impact of Azelnidipine and Amlodipine on Left Ventricular Mass and Longitudinal Function in Hypertensive Patients with Left Ventricular Hypertrophy
    Motoki, Hirohiko
    Koyama, Jun
    Izawa, Atsushi
    Tomita, Takeshi
    Miyashita, Yusuke
    Takahashi, Masafumi
    Ikeda, Uichi
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2014, 31 (10): : 1230 - 1238
  • [10] Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy
    Dahlof, B
    Zanchetti, A
    Diez, J
    Nicholls, MG
    Yu, CM
    Barrios, V
    Aurup, P
    Smith, RD
    Johansson, M
    JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1855 - 1864